e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net
All content for e-ESO Podcasts is the property of ESO - European School of Oncology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
e-ESO Podcasts
5 minutes 38 seconds
1 year ago
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
Expert: Radwa Hamed Sabra, Lecturer of Clinical Oncology, Armed Forces College of Medicine Egypt, Cairo, Egypt
e-ESO Podcasts
e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net
